Abstract
Background/Aim: This study aimed to create a predictive tool for estimating the remaining lifespan of patients after whole-brain irradiation (WBI) for cerebral metastases from bladder cancer. Patients and Methods: In 34 of these patients clinical parameters were analyzed for survival including age at start of WBI, gender, Karnofsky score, number of cerebral metastases and involvement of extra-cranial sites of metastasis. Results: Involvement of extra-cranial sites (14%) and Karnofsky score (9%) showed the greatest difference regarding 6-month survival and were considered for the tool. Points were assigned based on the following: no involvement of extra-cranial sites=1 point, involvement of extra-cranial sites=0 points, Karnofsky score =70=1 point, Karnofsky score =60=0 points. Patients’scores were 0, 1 or 2 points with 6-month survival rates of 13%, 27% and 50%, respectively. Conclusion: Based on two clinical parameters, a tool was developed that may help estimate the lifespan of patients irradiated for cerebral metastases from bladder cancer.
Original language | English (US) |
---|---|
Pages (from-to) | 633-636 |
Number of pages | 4 |
Journal | In Vivo |
Volume | 32 |
Issue number | 3 |
DOIs | |
State | Published - May 1 2018 |
Keywords
- Cancer of the bladder
- Cerebral metastases
- Estimation of survival
- Prognostic tool
- Whole-brain irradiation
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
- Pharmacology